Estrogen receptors: new players in diabetes mellitus

Trends in Molecular Medicine

Volumn 12, Issue 9, 2006, Pages 425-431

  Barros, Rodrigo P A ^a,b   Machado, Ubiratan Fabres ^b   Gustafsson, Jan Åke ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHRYSENE DERIVATIVE; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLUCOSE; GLUCOSE TRANSPORTER 4; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TETRAHYDROCHRYSENE; UNCLASSIFIED DRUG;

DIABETES MELLITUS; DRUG SELECTIVITY; ENERGY METABOLISM; ESTROGEN ACTIVITY; GENE EXPRESSION; GENE INTERACTION; GENE TARGETING; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; HUMAN; INSULIN SENSITIVITY; INTROSPECTION; MODULATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW;

ANIMALS; DIABETES MELLITUS, TYPE 2; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN REPLACEMENT THERAPY; FEMALE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HOMEOSTASIS; HUMANS; INSULIN; MALE;

EID: 33748136941     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2006.07.004     Document Type: Review

References (76)

1. Wild S., et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
2. No authors listed (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N. Engl. J. Med. 329, 977-986
3. Bjornholm M., and Zierath J.R. Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes. Biochem. Soc. Trans. 33 (2005) 354-357
4. Alberti K.G., et al. The metabolic syndrome - a new worldwide definition. Lancet 366 (2005) 1059-1062
5. Jensen E.V., and Jacobson H.I. Basic guides to the mechanism of estrogen action. Recent Prog. Horm. Res. 18 (1962) 387-414
6. Chambon P. The nuclear receptor superfamily: a personal retrospect on the first two decades. Mol. Endocrinol. 19 (2005) 1418-1428
7. Nilsson S., et al. Mechanisms of estrogen action. Physiol. Rev. 81 (2001) 1535-1565
8. Anderson G.L., et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 291 (2004) 1701-1712
9. Wynn V., and Doar J.W. Some effects of oral contraceptives on serum-lipid and lipoprotein levels. Lancet 2 (1966) 720-723
10. Case A.M., and Reid R.L. Menstrual cycle effects on common medical conditions. Compr. Ther. 27 (2001) 65-71
11. Solomon C.G., et al. Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus. JAMA 286 (2001) 2421-2426
12. Buchanan T.A., et al. Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am. J. Obstet. Gynecol. 162 (1990) 1008-1014
13. Kaaja R.J., and Greer I.A. Manifestations of chronic disease during pregnancy. JAMA. 294 (2005) 2751-2757
14. Dunaif A., et al. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38 (1989) 1165-1174
15. Fisher C.R., et al. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 6965-6970
16. Jones M.E., et al. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 12735-12740
17. Takeda K., et al. Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. J. Endocrinol. 176 (2003) 237-246
18. Faustini-Fustini M., et al. Oestrogen deficiency in men: where are we today?. Eur. J. Endocrinol. 140 (1999) 111-129
19. Lubahn D.B., et al. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 11162-11166
20. Bryzgalova G., et al. Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia 49 (2006) 588-597
21. Eckel R.H., et al. The metabolic syndrome. Lancet 365 (2005) 1415-1428
22. Gould G.W., and Holman G.D. The glucose transporter family: structure, function and tissue-specific expression. Biochem. J. 295 (1993) 329-341
23. Gaster M., et al. GLUT11, but not GLUT8 or GLUT12, is expressed in human skeletal muscle in a fibre type-specific pattern. Pflugers Arch. 448 (2004) 105-113
24. Zierath J.R., and Hawley J.A. Skeletal muscle fiber type: influence on contractile and metabolic properties. PLoS Biol. 2 (2004) e348
25. Kasuga M., et al. The structure of insulin receptor and its subunits. Evidence for multiple nonreduced forms and a 210,000 possible proreceptor. J. Biol. Chem. 257 (1982) 10392-10399
26. Zhou L., et al. Action of insulin receptor substrate-3 (IRS-3) and IRS-4 to stimulate translocation of GLUT4 in rat adipose cells. Mol. Endocrinol. 13 (1999) 505-514
27. Shi J., and Simpkins J.W. 17 β-Estradiol modulation of glucose transporter 1 expression in blood-brain barrier. Am. J. Physiol. 272 (1997) E1016-E1022
28. Welch R.D., and Gorski J. Regulation of glucose transporters by estradiol in the immature rat uterus. Endocrinology 140 (1999) 3602-3608
29. Cheng C.M., et al. Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex. FASEB J. 15 (2001) 907-915
30. Garvey W.T., et al. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM. Diabetes 41 (1992) 465-475
31. Garvey W.T., et al. Multiple defects in the adipocyte glucose transport system cause cellular insulin resistance in gestational diabetes. Heterogeneity in the number and a novel abnormality in subcellular localization of GLUT4 glucose transporters. Diabetes 42 (1993) 1773-1785
32. Okuno S., et al. Decreased expression of the GLUT4 glucose transporter protein in adipose tissue during pregnancy. Horm. Metab. Res. 27 (1995) 231-234
33. Rosenbaum D., et al. Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes. Am. J. Physiol. 264 (1993) E197-E202
34. Sugaya A., et al. Expression of glucose transporter 4 mRNA in adipose tissue and skeletal muscle of ovariectomized rats treated with sex steroid hormones. Life Sci. 66 (2000) 641-648
35. Campbell S.E., and Febbraio M.A. Effect of the ovarian hormones on GLUT4 expression and contraction-stimulated glucose uptake. Am. J. Physiol. Endocrinol. Metab. 282 (2002) E1139-E1146
36. Green S., et al. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320 (1986) 134-139
37. Greene G.L., et al. Sequence and expression of human estrogen receptor complementary DNA. Science 231 (1986) 1150-1154
38. Kuiper G.G., et al. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 5925-5930
39. Gosden J.R., et al. Localization of the human oestrogen receptor gene to chromosome 6q24-q27 by in situ hybridization. Cytogenet. Cell Genet. 43 (1986) 218-220
40. Enmark E., et al. Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern. J. Clin. Endocrinol. Metab. 82 (1997) 4258-4265
41. Klein-Hitpass L., et al. An estrogen-responsive element derived from the 5′ flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell 46 (1986) 1053-1061
42. Hall J.M., and McDonnell D.P. The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 140 (1999) 5566-5578
43. Katzenellenbogen B.S. Estrogen receptors: bioactivities and interactions with cell signaling pathways. Biol. Reprod. 54 (1996) 287-293
44. Koehler K.F., et al. Reflections on the discovery and significance of estrogen receptor β. Endocr. Rev. 26 (2005) 465-478
45. Dieudonne M.N., et al. Evidence for functional estrogen receptors α and β in human adipose cells: regional specificities and regulation by estrogens. Am. J. Physiol. Cell Physiol. 286 (2004) C655-C661
46. Wiik A., et al. Oestrogen receptor β is expressed in adult human skeletal muscle both at the mRNA and protein level. Acta Physiol. Scand. 179 (2003) 381-387
47. Barros R.P., et al. Muscle GLUT4 regulation by estrogen receptors ERβ and ERα. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 1605-1608
48. Patrone C., et al. Estradiol induces differential neuronal phenotypes by activating estrogen receptor α or β. Endocrinology 141 (2000) 1839-1845
49. Helguero L.A., et al. Estrogen receptors α (ERα) and β (ERβ) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Oncogene 24 (2005) 6605-6616
50. Krege J.H., et al. Generation and reproductive phenotypes of mice lacking estrogen receptor β. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 15677-15682
51. Shim G.J., et al. Autoimmune glomerulonephritis with spontaneous formation of splenic germinal centers in mice lacking the estrogen receptor α gene. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 1720-1724
52. Shim G.J., et al. Disruption of the estrogen receptor β gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 6694-6699
53. Shim G.J., et al. Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren's syndrome. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 12628-12633
54. -/-) mice. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 7165-7169
55. Wada-Hiraike O., et al. Role of estrogen receptor β in colonic epithelium. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 2959-2964
56. Imamov O., et al. Estrogen receptor β in health and disease. Biol. Reprod. 73 (2005) 866-871
57. Pettersson K., et al. Estrogen receptor β acts as a dominant regulator of estrogen signaling. Oncogene 19 (2000) 4970-4978
58. Maruyama S., et al. Suppression by estrogen receptor β of AP-1 mediated transactivation through estrogen receptor α. J. Steroid Biochem. Mol. Biol. 78 (2001) 177-184
59. Liu M.M., et al. Opposing action of estrogen receptors α and β on cyclin D1 gene expression. J. Biol. Chem. 277 (2002) 24353-24360
60. Lindberg M.K., et al. Estrogen receptor (ER)-β reduces ERα-regulated gene transcription, supporting a 'ying yang' relationship between ERα and ERβ in mice. Mol. Endocrinol. 17 (2003) 203-208
61. Qin C., et al. Transcriptional activation of insulin-like growth factor-binding protein-4 by 17β-estradiol in MCF-7 cells: role of estrogen receptor-Sp1 complexes. Endocrinology 140 (1999) 2501-2508
62. Galien R., and Garcia T. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-κB site. Nucleic Acids Res. 25 (1997) 2424-2429
63. Paech K., et al. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 277 (1997) 1508-1510
64. Heine P.A., et al. Increased adipose tissue in male and female estrogen receptor-α knockout mice. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 12729-12734
65. Naaz A., et al. Effect of ovariectomy on adipose tissue of mice in the absence of estrogen receptor α (ERα): a potential role for estrogen receptor β (ERβ). Horm. Metab. Res. 34 (2002) 758-763
66. Smith E.P., et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N. Engl. J. Med. 331 (1994) 1056-1061
67. Karlsson M., et al. Insulin induces translocation of glucose transporter GLUT4 to plasma membrane caveolae in adipocytes. FASEB J. 16 (2002) 249-251
68. Arnold J.T., et al. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells. Am. J. Physiol. Endocrinol. Metab. 288 (2005) E573-E584
69. Pitteloud N., et al. Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care 28 (2005) 1636-1642
70. Harrington W.R., et al. Activities of estrogen receptor α- and β-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol. Cell. Endocrinol. 206 (2003) 13-22
71. Kaestner K.H., et al. Mouse insulin-responsive glucose transporter gene: characterization of the gene and trans-activation by the CCAAT/enhancer binding protein. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 251-255
72. Kanda N., and Watanabe S. 17β-estradiol inhibits MCP-1 production in human keratinocytes. J. Invest. Dermatol. 120 (2003) 1058-1066
73. Salvatori L., et al. Oestrogens and selective oestrogen receptor (ER) modulators regulate EGF receptor gene expression through human ER α and β subtypes via an Sp1 site. Oncogene 22 (2003) 4875-4881
74. Long S.D., and Pekala P.H. Lipid mediators of insulin resistance: ceramide signalling down-regulates GLUT4 gene transcription in 3T3-L1 adipocytes. Biochem. J. 319 (1996) 179-184
75. Ruan H., et al. Tumor necrosis factor-α suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-κB activation by TNF-α is obligatory. Diabetes 51 (2002) 1319-1336
76. Silva J.L., et al. NF-κB, MEF2A, MEF2D and HIF1-a involvement on insulin- and contraction-induced regulation of GLUT4 gene expression in soleus muscle. Mol. Cell. Endocrinol. 240 (2005) 82-93